Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC), 2158-2159 [2022-00565]

Download as PDF 2158 Federal Register / Vol. 87, No. 9 / Thursday, January 13, 2022 / Notices Board of Governors of the Federal Reserve System, January 6, 2022. Michele Taylor Fennell, Deputy Associate Secretary of the Board. [FR Doc. 2022–00447 Filed 1–12–22; 8:45 am] Centers for Disease Control and Prevention BILLING CODE P [Docket No. CDC–2022–0001] FEDERAL RESERVE SYSTEM Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC) Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company jspears on DSK121TN23PROD with NOTICES1 DEPARTMENT OF HEALTH AND HUMAN SERVICES The notificants listed below have applied under the Change in Bank Control Act (Act) (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank holding company. The factors that are considered in acting on the applications are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The public portions of the applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Bank(s) indicated below and at the offices of the Board of Governors. This information may also be obtained on an expedited basis, upon request, by contacting the appropriate Federal Reserve Bank and from the Board’s Freedom of Information Office at https://www.federalreserve.gov/foia/ request.htm. Interested persons may express their views in writing on the standards enumerated in paragraph 7 of the Act. Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington, DC 20551–0001, not later than January 28, 2022. A. Federal Reserve Bank of Richmond (Adam M. Drimer, Assistant Vice President) 701 East Byrd Street, Richmond, Virginia 23219. Comments can also be sent electronically to or Comments.applications@rich.frb.org: 1. Dominik Mjartan and Georgia M. Mjartan, both of Columbia, South Carolina; to acquire voting shares of Optus Financial Corporation, and thereby indirectly acquire voting shares of Optus Bank, both of Columbia, South Carolina. Board of Governors of the Federal Reserve System, January 10, 2022. Michele Taylor Fennell, Deputy Associate Secretary of the Board. [FR Doc. 2022–00593 Filed 1–12–22; 8:45 am] BILLING CODE 6210–01–P VerDate Sep<11>2014 18:18 Jan 12, 2022 Jkt 256001 Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting and request for comment. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Advisory Committee to the Director, Centers for Disease Control and Prevention (ACD, CDC). This meeting is open to the public. Time will be available for public comment. The meeting will be webcast live via the World Wide Web. DATES: The meeting will be held on February 1, 2022, from 11:00 a.m. to 4:30 p.m., EST (times subject to change). The public may submit written comments from January 13, 2022 through January 28, 2022. ADDRESSES: You may submit comments identified by Docket No. CDC–2022– 0001 by any of the following methods: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. • Mail: Docket number CDC–2022– 0001, c/o Kerry Caudwell, MPA, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–10, Atlanta, Georgia 30329–4027. Instructions: All submissions received must include the Agency name and Docket Number. All relevant comments received in conformance with the https://www.regulations.gov suitability policy will be posted without change to https://www.regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to https://www.regulations.gov. Written public comments submitted up to 72 hours prior to the ACD meeting will be provided to ACD members before the meeting. Written comments received in advance of the meeting will be included in the official record of the meeting. FOR FURTHER INFORMATION CONTACT: Kerry Caudwell, MPA, Centers for Disease Control and Prevention, Office of the Chief of Staff, 1600 Clifton Road NE, MS H21–10, Atlanta, Georgia 30329–4027, Telephone: (404) 639– SUMMARY: PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 7000; Email Address: ACDirector@ cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Advisory Committee to the Director, CDC, shall advise the Secretary, HHS, and the Director, CDC, on policy and broad strategies that will enable CDC to fulfill its mission of protecting health through health promotion, prevention, and preparedness. The committee recommends ways to prioritize CDC’s activities, improve results, and address health disparities. It also provides guidance to help CDC work more effectively with its various private and public sector constituents to make health protection a practical reality. Matters To Be Considered: The agenda will include discussions on CDC’s current work and priorities as they relate to: (1) Health equity and (2) public health system infrastructure issues regarding data modernization and/or support for the public health workforce. Agenda items are subject to change as priorities dictate. Public Participation Interested persons or organizations are invited to participate by submitting written views, recommendations, and data. Please note that comments received, including attachments and other supporting materials, are part of the public record and are subject to public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display. CDC will review all submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/ near duplicate examples of a mass-mail campaign. CDC will carefully consider all comments submitted into the docket. Written Public Comment: The docket will be opened to receive written comments on January 13, 2022 through January 28, 2022. Oral Public Comment: This meeting will include time for members of the public to make an oral comment. Oral public comment will occur before any scheduled votes. Priority will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures below. E:\FR\FM\13JAN1.SGM 13JAN1 2159 Federal Register / Vol. 87, No. 9 / Thursday, January 13, 2022 / Notices Procedure for Oral Public Comment: All persons interested in making an oral public comment at the February 1, 2022 ACD meeting must submit a request by visiting https://www.cdc.gov/about/ advisory-committee-director/meetings no later than 11:59 p.m., EST, January 24, 2022, according to the instructions provided. If the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled time, CDC will conduct a lottery to determine the speakers for the scheduled public comment session. CDC staff will notify individuals regarding their request to speak by email by January 28, 2022. To accommodate the significant interest in participation in the oral public comment session of ACD meetings, each speaker will be limited to 3 minutes, and each speaker may only speak once per meeting. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–00565 Filed 1–12–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Proposed Information Collection Activity; Head Start Program Information Report (OMB #0970–0427) Office of Head Start, Administration for Children and Families, HHS. ACTION: Request for public comment. AGENCY: The Administration for Children and Families’ (ACF) Office of Head Start (OHS) is requesting a 3-year extension of the Head Start Program Information Report (PIR), Monthly Enrollment reporting instrument, and Center Locations and Contacts instrument (OMB #0970–0427, expiration 4/30/2022). OHS has made updates to these instruments, as described below. DATES: Comments due within 60 days of publication. In compliance with the requirements of the Paperwork Reduction Act of 1995, ACF is soliciting public comment on the specific aspects of the information collection described above. ADDRESSES: You can obtain copies of the proposed collection of information and submit comments by emailing infocollection@acf.hhs.gov. Identify all requests by the title of the information collection. SUPPLEMENTARY INFORMATION: SUMMARY: Description: OHS is requesting an extension, with changes, of the Head Start PIR information collection authority. The following instruments are included in this information collection: (1) PIR, (2) Monthly Enrollment, and (3) Center Locations and Contacts. The PIR is used for federal program management purposes including to promote decisionmaking using data, is a major source of information used to respond to Congressional and public inquiries about Head Start programs, and is used often by researchers. Monthly enrollment reporting supports oversight activities related to promoting full enrollment of programs. Center locations and contact reporting is used to help parents locate a program in their community. In general, these information collections together create key administrative datasets to support administration of the program. The proposed changes include new questions on the PIR to collect information on collaboration activities with Part C agencies and the average benefits provided to certain education staff as part of their compensation. Additionally, new questions were added to the centers reporting to capture participation in a local or state Quality Rating Improvement System and licensing status for each center. Lastly, minor changes were made to these instruments for clarification purposes. Respondents: Head Start Grant Recipients. ANNUAL BURDEN ESTIMATES Annual number of respondents Instrument jspears on DSK121TN23PROD with NOTICES1 Head Start PIR ................................................................................................ Monthly Enrollment .......................................................................................... Center Locations and Contacts ....................................................................... Estimated Total Annual Burden Hours: 11,760. Comments: The Department specifically requests comments on (a) whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the VerDate Sep<11>2014 18:18 Jan 12, 2022 Jkt 256001 Annual number of responses per respondent 1,600 1,600 1,600 Average burden hours per response 2.25 27 15 Annual burden hours 1 0.05 0.25 3,600 2,160 6,000 use of automated collection techniques or other forms of information technology. Consideration will be given to comments and suggestions submitted within 60 days of this publication. Authority: 42 U.S.C. 9801 et seq. DEPARTMENT OF HEALTH AND HUMAN SERVICES Mary B. Jones, ACF/OPRE Certifying Officer. Agency Information Collection Activities; Proposed Collection; Comment Request; Registration of Food Facilities [FR Doc. 2022–00502 Filed 1–12–22; 8:45 am] BILLING CODE 4184–40–P PO 00000 Food and Drug Administration [Docket No. FDA–2021–N–1302] AGENCY: Food and Drug Administration, HHS. ACTION: Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\13JAN1.SGM Notice. 13JAN1

Agencies

[Federal Register Volume 87, Number 9 (Thursday, January 13, 2022)]
[Notices]
[Pages 2158-2159]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-00565]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2022-0001]


Advisory Committee to the Director (ACD), Centers for Disease 
Control and Prevention (CDC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Advisory Committee to the 
Director, Centers for Disease Control and Prevention (ACD, CDC). This 
meeting is open to the public. Time will be available for public 
comment. The meeting will be webcast live via the World Wide Web.

DATES: The meeting will be held on February 1, 2022, from 11:00 a.m. to 
4:30 p.m., EST (times subject to change). The public may submit written 
comments from January 13, 2022 through January 28, 2022.

ADDRESSES: You may submit comments identified by Docket No. CDC-2022-
0001 by any of the following methods:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Docket number CDC-2022-0001, c/o Kerry Caudwell, 
MPA, Centers for Disease Control and Prevention, 1600 Clifton Road NE, 
MS H21-10, Atlanta, Georgia 30329-4027.
    Instructions: All submissions received must include the Agency name 
and Docket Number. All relevant comments received in conformance with 
the https://www.regulations.gov suitability policy will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov.
    Written public comments submitted up to 72 hours prior to the ACD 
meeting will be provided to ACD members before the meeting.
    Written comments received in advance of the meeting will be 
included in the official record of the meeting.

FOR FURTHER INFORMATION CONTACT: Kerry Caudwell, MPA, Centers for 
Disease Control and Prevention, Office of the Chief of Staff, 1600 
Clifton Road NE, MS H21-10, Atlanta, Georgia 30329-4027, Telephone: 
(404) 639-7000; Email Address: [email protected].

SUPPLEMENTARY INFORMATION:
    Purpose: The Advisory Committee to the Director, CDC, shall advise 
the Secretary, HHS, and the Director, CDC, on policy and broad 
strategies that will enable CDC to fulfill its mission of protecting 
health through health promotion, prevention, and preparedness. The 
committee recommends ways to prioritize CDC's activities, improve 
results, and address health disparities. It also provides guidance to 
help CDC work more effectively with its various private and public 
sector constituents to make health protection a practical reality.
    Matters To Be Considered: The agenda will include discussions on 
CDC's current work and priorities as they relate to: (1) Health equity 
and (2) public health system infrastructure issues regarding data 
modernization and/or support for the public health workforce. Agenda 
items are subject to change as priorities dictate.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data. Please note that 
comments received, including attachments and other supporting 
materials, are part of the public record and are subject to public 
disclosure. Comments will be posted on https://www.regulations.gov. 
Therefore, do not include any information in your comment or supporting 
materials that you consider confidential or inappropriate for public 
disclosure. If you include your name, contact information, or other 
information that identifies you in the body of your comments, that 
information will be on public display. CDC will review all submissions 
and may choose to redact, or withhold, submissions containing private 
or proprietary information such as Social Security numbers, medical 
information, inappropriate language, or duplicate/near duplicate 
examples of a mass-mail campaign. CDC will carefully consider all 
comments submitted into the docket.
    Written Public Comment: The docket will be opened to receive 
written comments on January 13, 2022 through January 28, 2022.
    Oral Public Comment: This meeting will include time for members of 
the public to make an oral comment. Oral public comment will occur 
before any scheduled votes. Priority will be given to individuals who 
submit a request to make an oral public comment before the meeting 
according to the procedures below.

[[Page 2159]]

    Procedure for Oral Public Comment: All persons interested in making 
an oral public comment at the February 1, 2022 ACD meeting must submit 
a request by visiting https://www.cdc.gov/about/advisory-committee-director/meetings no later than 11:59 p.m., EST, January 24, 2022, 
according to the instructions provided.
    If the number of persons requesting to speak is greater than can be 
reasonably accommodated during the scheduled time, CDC will conduct a 
lottery to determine the speakers for the scheduled public comment 
session. CDC staff will notify individuals regarding their request to 
speak by email by January 28, 2022. To accommodate the significant 
interest in participation in the oral public comment session of ACD 
meetings, each speaker will be limited to 3 minutes, and each speaker 
may only speak once per meeting.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-00565 Filed 1-12-22; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.